Marimed Inc
OTC:MRMD
Marimed Inc
OTC:MRMD
Price:
0.0877
USD
9.9%
Market Closed
Market Cap:
$34.6m
Balance Sheet
Balance Sheet Decomposition
Marimed Inc
Marimed Inc
Balance Sheet Decomposition is not available for
Marimed Inc
Marimed Inc
Balance Sheet
Marimed Inc
Marimed Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
1
|
1
|
4
|
1
|
3
|
30
|
10
|
15
|
7
|
|
| Cash Equivalents |
0
|
1
|
0
|
1
|
1
|
4
|
1
|
3
|
30
|
10
|
15
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
3
|
9
|
2
|
7
|
2
|
7
|
7
|
9
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
2
|
5
|
2
|
7
|
2
|
4
|
7
|
9
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
4
|
0
|
1
|
0
|
3
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
7
|
10
|
20
|
25
|
33
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
8
|
4
|
4
|
|
| Total Current Assets |
0
|
1
|
1
|
2
|
5
|
16
|
7
|
21
|
45
|
44
|
51
|
54
|
|
| PP&E Net |
0
|
0
|
2
|
5
|
26
|
34
|
49
|
51
|
67
|
77
|
102
|
107
|
|
| PP&E Gross |
0
|
0
|
0
|
5
|
26
|
34
|
49
|
51
|
67
|
77
|
102
|
107
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
5
|
7
|
10
|
15
|
22
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
14
|
17
|
19
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
12
|
16
|
|
| Note Receivable |
0
|
0
|
1
|
1
|
1
|
31
|
2
|
1
|
9
|
8
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
13
|
11
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
12
|
16
|
|
| Total Assets |
0
N/A
|
2
N/A
|
4
+118%
|
9
+132%
|
32
+274%
|
83
+158%
|
62
-26%
|
76
+24%
|
123
+61%
|
152
+24%
|
196
+29%
|
207
+6%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
2
|
1
|
3
|
4
|
5
|
5
|
5
|
7
|
9
|
13
|
|
| Accrued Liabilities |
1
|
0
|
0
|
2
|
1
|
2
|
6
|
5
|
4
|
4
|
5
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
4
|
11
|
4
|
23
|
9
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
2
|
7
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
2
|
2
|
17
|
12
|
14
|
22
|
|
| Total Current Liabilities |
1
|
2
|
2
|
6
|
15
|
10
|
37
|
23
|
27
|
27
|
31
|
49
|
|
| Long-Term Debt |
0
|
2
|
3
|
3
|
6
|
11
|
13
|
26
|
17
|
26
|
68
|
72
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
5
|
4
|
9
|
8
|
|
| Total Liabilities |
1
N/A
|
3
+200%
|
6
+73%
|
10
+70%
|
21
+121%
|
21
-2%
|
55
+160%
|
53
-3%
|
48
-10%
|
56
+17%
|
106
+90%
|
126
+20%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
15
|
38
|
38
|
19
|
19
|
|
| Retained Earnings |
1
|
8
|
9
|
10
|
12
|
26
|
107
|
105
|
97
|
84
|
100
|
112
|
|
| Additional Paid In Capital |
1
|
6
|
7
|
9
|
22
|
87
|
112
|
113
|
135
|
142
|
171
|
173
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
-70%
|
2
-18%
|
1
+45%
|
11
N/A
|
62
+474%
|
7
-89%
|
23
+239%
|
76
+223%
|
97
+28%
|
91
-6%
|
81
-11%
|
|
| Total Liabilities & Equity |
0
N/A
|
2
N/A
|
4
+118%
|
9
+132%
|
32
+274%
|
83
+158%
|
62
-26%
|
76
+24%
|
123
+61%
|
152
+24%
|
196
+29%
|
207
+6%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
32
|
64
|
65
|
64
|
177
|
211
|
228
|
314
|
334
|
342
|
375
|
381
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
